In 2011, increased Bax expression and subsequent improved sensitivity to TRAIL was reported in colon cancer cells following exposure to the plant derived compound Nimbolide [175], although it is important to note that this article has since been retracted by the publisher. This evidence concerns the gene BAX and malignant colon neoplasm.